Skip to main content
. 2012 Winter;23(4):173–178. doi: 10.1155/2012/361292

TABLE 1.

Characteristics of patients with tuberculosis according to outcome (n=53)

All patients (n=53) Survivors (n=33) Nonsurvivors (n=20) OR (95% CI) P
Demographic parameters
  Age, years 41 (32–52) 40 (30–47) 45 (34–55) 5 (−7 to 15) 0.3
  Sex ratio, male to female, n/n 40/13 26/7 14/6 −8.8 (−35.8 to 18.6) 0.5
  Body mass index, kg/m2 20 (17–24) 20 (17–26) 21 (17–23) 1 (−3 to 5) 0.9
  HIV infection, n (%) 12 (23) 7 (21) 5 (25) 4.4 (−24.9 to 33.3) 0.7
  Homeless, n (%) 17 (32) 7 (21) 10 (50) 28.8 (2.8 to 54.8) 0.04
Clinical features
    Temperature, °C 38.7 (37.6–39.6) 38.9 (37.8–39.9) 38.1 (37.3–39.1) −0.9 (−1.8 to 0.5) 0.05
  Glasgow Coma score 14 (12–15) 15 (13–15) 13 (7–15) −2 (−7 to 0) 0.01
  Systolic blood pressure, mmHg 96 (80–118) 105 (94–119) 80 (65–104) −25 (−38 to −2) 0.004
  Heart rate, beats/min 125 (105–143) 119 (101–138) 135 (121–145) 16 (−1 to 35) 0.1
  Respiratory rate, breaths/min 31 (25–38) 29 (24–34) 35 (30–45) 6.5 (0.1 to 14) 0.03
  Extrapulmonary involvement, n (%) 15 (28) 10 (30) 5 (25) −5.3 (−29.9 to 19.3) 0.7
Radiological findings
  Miliary syndrome, n (%) 13 (25) 5 (15) 8 (40) 24.8 (−2.7 to 50.3) 0.05
  Multilobar involvement (≥3 lobes), n (%) 28 (53) 12 (38) 16 (84) 46.7 (23.3 to 70.2) 0.001
Biological parameters
  PaO2/FiO2, mmHg 285 (188–385) 347 (265–441) 170 (109–342) −177 (−288 to −1) 0.002
  HCO3−, mmol/L 24.0 (20.0–28.0) 24.0 (22.0–27.0) 22.5 (19.5–28.5) −1.5 (−5 to 3.5) 0.4
  Plasma lactate concentration, mmol/L 1.9 (1.2–3.0) 1.5 (1.0–2.4) 2.3 (1.8–4.7) 0.8 (0.1 to 3.1) 0.02
  Prothrombin index*, % 73 (59–82) 75 (72–86) 61 (46–78) −14 (−26 to 0) 0.01
  Serum creatinine, μmol/L 66 (52–90) 68 (52–81) 63 (46–121) −5 (−21 to 31) 0.9
  C-reactive protein, mg/L 95 (32–188) 65 (21–134) 122 (95–235) 57 (19 to 163) 0.02
Physiological score
  SAPS II 31 (22–50) 28 (20–34) 50 (36–69) 22 (13 to 41) 0.0002
  Acute renal injury, n (%) 5 (9) 1 (3) 4 (20) 17 (−10.7 to 43.2) 0.06
Microbiological data
  Positive direct examinations, n (%) 30 (57) 14 (42) 16 (80) 34.5 (10.1 to 59) 0.021
  Delay to the first microbiological proof, days 4 (1–28) 19 (2–29) 1 (1–11) −18 (−23 to 0) 0.07
  Delay to positive Mycobacterium tuberculosis culture, days 19 (10–29) 21 (12–31) 14 (10–22) −8 (−14 to 1) 0.09
Management in the intensive care unit (ICU)
  Mechanical ventilation on admission, n (%) 24 (45) 7 (21) 17 (85) 63.8 (42.8 to 84.8) <0.0001
  Duration, days 6 (3–17) 6 (3–27) 6 (2–17) 0 (−8 to 23) 0.7
  Vasopressor infusion on admission, n (%) 15 (28) 2 (6) 13 (65) 58.9 (36.5 to 81.4) <0.0001
  Antituberculosis therapy in the ICU, n (%) 40 (75) 21 (64) 19 (95) 31.4 (3.5 to 55.6) 0.02
  Delay, days 3 (0–21) 4 (2–23) 2 (0–7) −2 (−19 to 0) 0.04
  Hemodialysis, n (%) 9 (17) 1 (3) 8 (40) 37 (9.8 to 60.8) 0.001
Outcome
  Length of ICU stay, days 6 (3–16) 6 (3–13) 8 (3–19) 2 (−4 to 10) 0.7
  Hospital-acquired infections, n (%) 11 (21) 2 (6) 9 (45) 38.9 (11.8 to 62.5) 0.001

Data presented as median (interquartile range) unless otherwise indicated. Bolded values indicate statistical significance.

*

Prothrombin index (in which a decrease corresponds to an increase in prothrombin time or internationalized normalized ratio) represents the percentage of the patient-to-normal value ratio;

Acute renal injury was determined using the definition and the estimated baseline creatinine according to Bellomo et al (9);

Delay to the first microbiological proof of tuberculosis: delay between intensice care unit (ICU) admission and the date of either a positive direct examination or a positive culture when the direct examination was negative. PaO2/FiO2 Ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen; SAPS II Simplified Acute Physiology score II